Literature DB >> 26141500

Construction of a Quality of Life Questionnaire for slowly progressive neuromuscular disease.

Antoine Dany1,2,3, Coralie Barbe4,5, Amandine Rapin4,5, Christian Réveillère6, Jean-Benoit Hardouin7, Isabella Morrone4,5, Aurore Wolak-Thierry4,5, Moustapha Dramé4,5, Arnaud Calmus4,5, Sabrina Sacconi8, Guillaume Bassez6, Vincent Tiffreau9, Isabelle Richard10, Benjamin Gallais11, Hélène Prigent12, Redha Taiar4, Damien Jolly4,5, Jean-Luc Novella4,5, François Constant Boyer4,5,13.   

Abstract

PURPOSE: To build a questionnaire to assess health-related quality of life (HRQL) in patients suffering from slowly progressive neuromuscular disease (NMD) using item response theory (IRT).
METHODS: A pool of 64 items and a validated questionnaire (WHOQOL-BREF) were administered to 159 patients recruited in eight NMD referral centers. Exploratory statistical analysis included methods derived from both IRT and classical test theory.
RESULTS: We constructed a questionnaire named QoL-NMD which is composed of two general items and 24 items classified in three domains: (1) "Impact of Physical Symptoms," (2) "Self-perception" and (3) "Activities and Social Participation." Each domain has good psychometric properties (Cronbach's alpha > 0.77, test-retest ICC > 0.81, Loevinger's H > 0.41) and meets IRT assumptions. Comparison with the WHOQOL-BREF enabled assessing similarities and discrepancies with a generic questionnaire.
CONCLUSION: This study enabled the development of a new HRQL questionnaire specifically designed for slowly progressive NMD patients. The QoL-NMD is short enough to be used in clinical practice (26 items). The next steps will be to validate QoL-NMD by re-assessing psychometrics in an independent sample of patients and calibrate the IRT scoring system.

Entities:  

Keywords:  Item response theory; Neuromuscular disease; Outcome research; Patient outcome assessment; Quality of life

Mesh:

Year:  2015        PMID: 26141500     DOI: 10.1007/s11136-015-1013-8

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  17 in total

1.  The World Health Organization's WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial. A report from the WHOQOL group.

Authors:  S M Skevington; M Lotfy; K A O'Connell
Journal:  Qual Life Res       Date:  2004-03       Impact factor: 4.147

2.  On the Theory of Scales of Measurement.

Authors:  S S Stevens
Journal:  Science       Date:  1946-06-07       Impact factor: 47.728

Review 3.  Patient-reported outcomes: assessment and current perspectives of the guidelines of the Food and Drug Administration and the reflection paper of the European Medicines Agency.

Authors:  Andrew Bottomley; Dave Jones; Lily Claassens
Journal:  Eur J Cancer       Date:  2008-11-14       Impact factor: 9.162

4.  Qualitative research. Introducing focus groups.

Authors:  J Kitzinger
Journal:  BMJ       Date:  1995-07-29

5.  Health related quality of life in people with hereditary neuromuscular diseases: an investigation of test-retest agreement with comparison between two generic questionnaires, the Nottingham health profile and the short form-36 items.

Authors:  F Boyer; I Morrone; I Laffont; O Dizien; J C Etienne; J L Novella
Journal:  Neuromuscul Disord       Date:  2006-01-19       Impact factor: 4.296

6.  Construction and validation of a quality of life questionnaire for neuromuscular disease (INQoL).

Authors:  K A Vincent; A J Carr; J Walburn; D L Scott; M R Rose
Journal:  Neurology       Date:  2007-03-27       Impact factor: 9.910

7.  Assessment of pain and health-related quality of life in slowly progressive neuromuscular disease.

Authors:  Richard T Abresch; Gregory T Carter; Mark P Jensen; David D Kilmer
Journal:  Am J Hosp Palliat Care       Date:  2002 Jan-Feb       Impact factor: 2.500

8.  The Patient-Reported Outcomes Measurement Information System (PROMIS): progress of an NIH Roadmap cooperative group during its first two years.

Authors:  David Cella; Susan Yount; Nan Rothrock; Richard Gershon; Karon Cook; Bryce Reeve; Deborah Ader; James F Fries; Bonnie Bruce; Mattias Rose
Journal:  Med Care       Date:  2007-05       Impact factor: 2.983

9.  Validation of the ICF core set for neuromuscular diseases.

Authors:  I Bos; H A Stallinga; B Middel; J B M Kuks; K Wynia
Journal:  Eur J Phys Rehabil Med       Date:  2012-11-21       Impact factor: 2.874

10.  Universal health outcome measures for older persons with multiple chronic conditions.

Authors: 
Journal:  J Am Geriatr Soc       Date:  2012-11-29       Impact factor: 5.562

View more
  4 in total

1.  Producing a preference-based quality of life measure for people with Duchenne muscular dystrophy: a mixed-methods study protocol.

Authors:  Philip A Powell; Jill Carlton; Donna Rowen; John E Brazier
Journal:  BMJ Open       Date:  2019-03-09       Impact factor: 2.692

2.  Quality of life and subjective symptom impact in Japanese patients with myotonic dystrophy type 1.

Authors:  Haruo Fujino; Toshio Saito; Masanori P Takahashi; Hiroto Takada; Takahiro Nakayama; Osamu Imura; Tsuyoshi Matsumura
Journal:  BMC Neurol       Date:  2022-02-14       Impact factor: 2.474

3.  Exploring the psychosocial impact of simple robotic assistive technology on adolescents with neuromuscular disease.

Authors:  Laura Oldford; Natasha Hanson; Isabelle Ross; Emma Croken; Lise Bleau
Journal:  J Rehabil Assist Technol Eng       Date:  2022-04-01

4.  A team approach in the diagnosis and management of facioscapulohumeral muscular dystrophy: a case report.

Authors:  Robert L Parisien; Joanne Zhang; Tony Tannoury; Andrew Stein; Xinning Li
Journal:  JSES Int       Date:  2020-06-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.